Clinical Trial Update: Antidepressant Effects of TS-161 in Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

The Phase 2 study of TS-161 for treatment-resistant depression was terminated, and trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• TS-161

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Major Depressive Disorder, Treatment-Resistant Depression | Phase 2 | Status: TERMINATED | Results posted: 2025-06-10